TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 1 | -1 | -4 | -30 | -61 | -91 | -31 |
| P | %wins | 100 | 50 | 50 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/3/15 16:54 | 7/30/15 | VRX | Valeant Pharmaceuticals International, Inc. | A8 | Health | Drug | Pharmaceutical Preparations | Rosiello Robert L. | NJ | O | EVP,CFO | P.m | 2,002 | 254.28 | 33 | 8 | 2 | 442 | D | 175 | 119 | 61 | 15 | 13 | 10 | 8 | 0 | 1 | -4 | -10 | -57 | -63 | -92 |
6/16/15 16:01 | 6/12/15 | VRX | Valeant Pharmaceuticals International, Inc. | A8 | Health | Drug | Pharmaceutical Preparations | Rosiello Robert L. | NJ | O | EVP | P | 2,999 | 232.51 | 33 | 13 | New | 13 | D | 169 | 93 | 66 | 14 | 3 | -2 | -1 | 1 | 1 | 2 | 3 | -3 | -59 | -89 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |